含有大麻的纳米乳液具有改善的生物可访问性和抗炎活性
Yuna Lee1, Sang Hoon Kim1, Ha-Yeon Song1
1Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, 29 Geumgu-gil, Jeongeup 56212, Republic of Korea.
ACS omega
|November 3, 2025
概括
这项研究开发了一种用于口服大麻素 (CBD) 输送的新型纳米乳液,显著提高了其生物可用性和抗炎作用. 这种纳米乳液在治疗和营养药物应用方面表现有前途.
科学领域:
- 制药科学 制药科学
- 纳米技术纳米技术
- 生物化学 生物化学
背景情况:
- 由于水溶性较差和生物可用性较低,口服大麻 (CBD) 面临着挑战.
- 这些限制限制了CBD在各种健康状况中的治疗潜力.
研究的目的:
- 开发和表征一种含有CBD的纳米乳液 (CBD-NE),使用OSA修饰的粉.
- 评估CBD-NE系统的增强生物可访问性和抗炎疗效.
主要方法:
- 使用OSA改性粉制备含有CBD的油入水纳米乳液.
- 纳米乳液颗粒大小,封装效率和体稳定性的表征.
- 通过模拟胃肠道消化对CBD生物可访问性的评估.
- 使用RAW264.7巨细胞和促炎性细胞因子试验对抗炎活性进行体外评估.
主要成果:
- CBD-NE的颗粒大小小 (39.18 nm) 和封装效率高 (99.80%).
- 纳米乳液在28天内表现出优异的体稳定性.
- 在模拟消化后,CBD-NE与未配制的CBD相比显示出显著更高的生物可访问性.
- CBD-NE有效地抑制了巨细胞中促炎性细胞因子 (IL-6,TNF-α) 的分泌.
结论:
- 开发的OSA修饰的粉纳米乳液有效地增强了口服CBD的输送.
- 改善的生物可访问性和强大的抗炎性质表明CBD-NE.有显著的治疗和营养潜力.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
182
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
182
Bioavailability Enhancement: Drug Solubility Enhancement
210
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
210
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
188
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
188
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
658
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
658
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
165
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
165


